AnthroTronix and Pelion Healthcare Group Announce Joint Venture to Bring Brain Vital Products to European Market

AnthroTronix and Pelion Healthcare Group Announce Joint Venture to Bring Brain Vital Products to European Market ****** Mobile Tool to Monitor and Evaluate Brain Health Will Now be Available for Consumers and Health Care Professionals Silver Spring, Md. and Łódź, Poland – AnthroTronix and Pelion Healthcare Group have signed a joint venture agreement forming a new company, DANA Brain Vital Europe LTD, with each owning half of the newly established company. The new venture is responsible for developing products based on the DANA platform and distributing them in European markets. Products will be marketed using the “CogniNET” brand within Pelion. DANA, which received FDA clearance in October 2014, is a mobile medical app that can be used on a phone or tablet and works on both the Android and iOS operating systems. DANA administers game-like tests that can provide data within minutes to help assess and measure a person’s brain/cognitive health. The app can help clinicians track cognitive function during treatment for such conditions as depression, dementia/Alzheimer’s Disease, and Post-Traumatic Stress Disorder (PTSD). “We are excited to partner with Pelion to bring DANA not just to health care professionals but also to consumers in Europe,” said Dr. Cori Lathan, @clathan, founder and CEO of AnthroTronix. “Along with tracking and evaluation done by medical professionals, individuals now will be able to track their brain health over time, allowing them to identify patterns in their own cognitive efficiency.” “It is exciting that we can combine 26 years of Pelion’s experience in the healthcare sector and the latest achievements in the area of science represented by AnthroTronix, with the expectations of patients,” said...